Doopadagiri Bio-Tech Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 2.00 M
- Company Age 21 Year, 7 Months
- Last Filing with ROC 31 Mar 2021
- Satisfied Charges ₹ 6.20 M
- Revenue Growth -21.57%
- Profit Growth -32.15%
- Ebitda -34.84%
- Net Worth -35.02%
- Total Assets 15.65%
About Doopadagiri Bio-Tech
Doopadagiri Bio-Tech Private Limited (DBPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 June 2003 and has a history of 21 years and seven months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company has closed loans amounting to ₹6.20 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Prema and Munivenkataramanappa Raju serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51102KA2003PTC032156
-
Company No.
032156
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Jun 2003
-
Date of AGM
30 Sep 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Doopadagiri Bio-Tech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prema | Director | 22-Jun-2021 | Current |
Munivenkataramanappa Raju
|
Director | 22-Jun-2021 | Current |
Financial Performance of Doopadagiri Bio-Tech.
Doopadagiri Bio-Tech Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 21.57% decrease. The company also saw a substantial fall in profitability, with a 32.15% decrease in profit. The company's net worth observed a substantial decline by a decrease of 35.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Doopadagiri Bio-Tech?
In 2021, Doopadagiri Bio-Tech had a promoter holding of 25.00% and a public holding of 75.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹6.20 M
Charges Breakdown by Lending Institutions
- Canara Bank : 0.62 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Jan 2009 | Canara Bank | ₹1.00 M | Satisfied |
| 31 Aug 2005 | Canara Bank | ₹5.20 M | Satisfied |
How Many Employees Work at Doopadagiri Bio-Tech?
Unlock and access historical data on people associated with Doopadagiri Bio-Tech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Doopadagiri Bio-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Doopadagiri Bio-Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
